Chemical activators of RWDD2A can engage multiple cellular signaling pathways to elicit functional activation of the protein. Phorbol 12-myristate 13-acetate, commonly known as PMA, directly activates protein kinase C (PKC), which in turn can phosphorylate RWDD2A, leading to its functional enhancement. This activation process is a classic example of signal transduction involving PKC, which plays a pivotal role in various cellular processes. Similarly, Forskolin raises intracellular cAMP levels, thereby activating protein kinase A (PKA). The activation of PKA can result in the phosphorylation of RWDD2A or its associated proteins, thus promoting RWDD2A's activity. Ionomycin, as another example, increases intracellular calcium concentrations, subsequently activating calmodulin-dependent kinases that can also target RWDD2A for phosphorylation. This phosphorylation serves as a regulatory mechanism, changing the functional state of the protein.
Another cAMP analog, 8-Bromo-cAMP, emulates the action of Forskolin by activating PKA, with the same potential for RWDD2A activation through phosphorylation. Okadaic Acid and Calyculin A, both inhibitors of protein phosphatases, lead to the accumulation of phosphorylated proteins, including RWDD2A, therefore activating it. Anisomycin triggers the MAP kinase pathway, which can result in the activation of RWDD2A through the action of MAP kinases. Thapsigargin, by inducing endoplasmic reticulum stress, may activate RWDD2A through the unfolded protein response, a complex network of signaling pathways aiming to restore normal cell function. Bisindolylmaleimide I, although a PKC inhibitor, can at low concentrations activate PKC, leading to downstream phosphorylation and activation of RWDD2A. Dibutyryl-cAMP, another cAMP analog, activates PKA, which might directly phosphorylate RWDD2A, thus promoting its activation. Lithium Chloride, by inhibiting GSK-3, can lead to the activation of RWDD2A by preventing inhibitory phosphorylation. Lastly, Staurosporine, a well-known PKC activator, can facilitate the phosphorylation and subsequent activation of RWDD2A, adding to the repertoire of chemical activators that utilize phosphorylation as a means to modulate RWDD2A activity.
VOIR ÉGALEMENT...
Items 1 to 10 of 12 total
Afficher:
| Nom du produit | CAS # | Ref. Catalogue | Quantité | Prix HT | CITATIONS | Classement |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activateur direct de la protéine kinase C (PKC) qui peut phosphoryler RWDD2A, ce qui entraîne son activation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Augmente les niveaux d'AMPc qui activent la protéine kinase A (PKA). La phosphorylation de la PKA peut activer la RWDD2A en la phosphorylant ou en phosphorant des protéines associées. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Augmente les niveaux de calcium intracellulaire, activant indirectement les kinases dépendantes de la calmoduline qui pourraient phosphoryler et activer RWDD2A. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $97.00 $224.00 | 30 | |
Analogue de l'AMPc qui active la PKA, conduisant à une phosphorylation potentielle de RWDD2A, entraînant son activation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Inhibiteur des protéines phosphatases 1 et 2A, entraînant une augmentation de la phosphorylation et donc de l'activation des protéines, y compris RWDD2A. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000C | 10 µg 100 µg 1 mg | $160.00 $750.00 $3000.00 | 59 | |
Inhibe les protéines phosphatases, ce qui entraîne l'activation de RWDD2A par une phosphorylation accrue. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Active la voie des MAP kinases, ce qui pourrait conduire à l'activation de RWDD2A par phosphorylation par les MAP kinases. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Induit un stress du RE conduisant à l'activation de la réponse aux protéines non pliées qui peut activer RWDD2A par des voies de signalisation cellulaires adaptatives. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
Inhibiteur spécifique de la PKC qui, à de faibles concentrations, peut paradoxalement activer la PKC, ce qui entraîne une activation en aval de RWDD2A par phosphorylation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
Analogue de l'AMPc qui active la PKA; la PKA peut alors phosphoryler et activer le RWDD2A. | ||||||